Ophthalmology · Los Angeles, CA
NPI
1487866588
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3055 Wilshire Blvd Ste 100
Los Angeles, CA, 90010
Phone (213) 484-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$225K
4,853 services
Medicare patients, 2024
556
Average age 77
Drug cost, 2024
$6.0M
17,964 prescriptions
Company payments, 2025
$2,026
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward W Lee was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,070 times for 15 patients. In total Edward W Lee billed 4,853 services in 55 codes, and Medicare paid $225K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,070 | 15 | $4.94 | $10K |
| 92012 Ophthalmological E&M | Office | 1,037 | 458 | $67.24 | $70K |
| 92134 Computerized Ophthalmic Imaging | Office | 339 | 254 | $30.14 | $10K |
| 92133 Computerized Ophthalmic Imaging | Office | 176 | 163 | $26.38 | $4,644 |
| 92083 Vision, Hearing, and Speech Services | Office | 162 | 149 | $49.92 | $8,086 |
| 68761 Eye | Office | 157 | 91 | $124.26 | $20K |
| 92273 Test - Miscellaneous | Office | 128 | 125 | $101.20 | $13K |
| 92004 Ophthalmological E&M | Office | 109 | 109 | $107.31 | $12K |
| 92285 Standard X-ray | Office | 94 | 80 | $17.16 | $1,613 |
| 92136 Ultrasound - Nonspecific | Office | 90 | 88 | $35.54 | $3,199 |
| 92250 Angiography | Office | 68 | 58 | $29.28 | $1,991 |
| 92082 Vision, Hearing, and Speech Services | Office | 53 | 53 | $38.12 | $2,021 |
| 68840 Eye | Office | 44 | 37 | $111.02 | $4,885 |
| 76514 Ultrasound - Nonspecific | Office | 37 | 37 | $8.36 | $309 |
| 67904 Eye | Facility | 32 | 32 | $694.75 | $22K |
By year: 2022 $312K for 5,690 services; 2023 $323K for 5,661 services; 2024 $225K for 4,853 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward W Lee prescribed most often to Medicare patients was Restasis (Cyclosporine), with 2,987 prescriptions and refills. In total Edward W Lee wrote 17,964 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 2,987 | 4,261 | 845 | $2.7M |
| Latanoprost Generic | 2,305 | 4,272 | 613 | $25K |
| Erythromycin Erythromycin Base | 2,007 | 2,101 | 1,012 | $18K |
| Cyclosporine Generic | 1,169 | 1,999 | 472 | $536K |
| Lumigan Bimatoprost | 1,088 | 1,482 | 228 | $372K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 967 | 1,760 | 221 | $14K |
| Xiidra Lifitegrast | 768 | 1,053 | 227 | $717K |
| Azelastine Hcl Generic | 764 | 1,066 | 253 | $9,584 |
| Brimonidine Tartrate Generic | 729 | 1,100 | 180 | $67K |
| Ketorolac Tromethamine Generic | 521 | 721 | 314 | $7,879 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 417 | 430 | 339 | $3,778 |
| Miebo Perfluorohexyloctane/Pf | 389 | 450 | 135 | $343K |
| Prednisolone Acetate Generic | 336 | 482 | 202 | $9,543 |
| Alphagan P Brimonidine Tartrate | 319 | 449 | 84 | $95K |
| Timolol Maleate Generic | 293 | 576 | 93 | $2,063 |
Brand drugs: 9,319 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward W Lee $2,026 ($2,026 in general payments such as food, travel and fees) from 12 companies. The largest payer was Bausch & Lomb Americas Inc. with $552.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 23 | $552 |
| Abbvie Inc. ABBV | 18 | $326 |
| Tarsus Pharmaceuticals, Inc. TARS | 9 | $314 |
| Sight Sciences, Inc. SGHT | 4 | $213 |
| Amgen Inc. AMGN | 10 | $201 |
| Alcon Vision LLC ALC | 7 | $135 |
| Nova Eye, Inc. | 1 | $75.24 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $63.13 |
| Harrow Eye, LLC | 2 | $49.7 |
| RxSight Inc RXST | 2 | $43.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.